Healthpeak Q1 - The "Best" In The Space With A 15% Upside

Monty Rakusen Dear subscribers, Some continue to be dubious about investing in a REIT like Healthpeak (NYSE:DOC), which I have been purchasing for the past 6 months, at prices below $17/share, which has led me to my current cost basis for the company of well below $17.5/share and a yield of over 7% for this BBB-rated equivalent REIT. With its diverse portfolio of life science properties, outpatient medical care facilities, and continuing care retirement communities, it has a very interesting mix of assets, ...